Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnox 520 for Nocturnal Leg Cramps
NCT01709968Phase 4Terminated
- Start
- Feb 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nocturnal leg cramps (NLC) comparing MAGNOX 520 with Placebo (2 arms). Primary endpoint: Number of documented episodes of Nocturnal Leg Cramps at 4 weeks. Started Feb 2013; status: terminated.
02
Drugs
magnesium
03
Conditions
nocturnal leg cramps (NLC)
Beyond the preview
Go deeper on NCT01709968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01709968.